BPC
PTCT icon

Banque Pictet & Cie’s PTC Therapeutics PTCT Stock Holding History

Banque Pictet & Cie’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,057
Closed -$384K – 449
2025
Q4 		$384K Sell
5,057
-1,186
-19% -$86.2K ﹤0.01% 331
2025
Q3 		$383K Sell
6,243
-40
-0.6% -$2.08K ﹤0.01% 349
2025
Q2 		$307K Sell
6,283
-422
-6% -$20K ﹤0.01% 336
2025
Q1 		$342K Buy
+6,705
New +$335K ﹤0.01% 347

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Banque Pictet & Cie's PTCT Position: Q1 2026 in Review

Banque Pictet & Cie sold out of PTC Therapeutics (PTCT) in Q1 2026, closing a stake of 5,057 shares — an estimated $384K sold.

Banque Pictet & Cie first reported a position in PTCT in Q1 2025 and held it in 4 quarters. The position peaked at $384K in Q4 2025. 352 funds tracked by Wall St. Rank hold PTCT as of Q1 2026.

  • Banque Pictet & Cie reported no remaining PTC Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Banque Pictet & Cie sold 5,057 PTC Therapeutics shares in Q1 2026, an estimated $384K.
  • Banque Pictet & Cie first reported a position in PTC Therapeutics in Q1 2025 and held it in 4 quarters.
  • Banque Pictet & Cie's PTC Therapeutics position peaked at $384K in Q4 2025.
  • 352 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2026.

Based on Banque Pictet & Cie's 13F filing for Q1 2026, filed 14 Apr 2026.